1. Ameyaw MM, Regateiro F, Li T, et al (2001) MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11:217–221
2. Angst J (1961) A clinical analysis of the effects of tofranil in depression: longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacologia 2:381–407
3. Arias B, Catalan R, Gasto C, et al (2001) Genetic variability in the promotor region of the serotonin transporter gene is associated with clinical remission of major depression after long-term treatment with citalopram. World J Biol Psychiatry 2:9S
4. Benedetti F, Serretti A, Colombo C, et al (1999) Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 156:1450–1452
5. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papitol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Bruckl T, Muller N, Pfister H, Lieb R, Mueller JC, Lohmussaar E, Strom TM, Betttecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36(12):1319–1325